Concepedia

Elahe Minaei

EM

Statistics

Publications

9

Citations

246

H-Index

9

Active since

2016

Affiliations

University of Wollongong(Current)

Illawarra Health and Medical Research Institute

Royal Prince Alfred Hospital

Chris O’Brien Lifehouse

Illawarra Shoalhaven Local Health District

Elahe Minaei is an author at University of Wollongong specializing in drug resistance, drug development, and drug discovery.

ORCID

Top concepts

Publications per year

2016–2022

9

Publications

9

6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer

Benjamin J. Buckley, Ashraf Aboelela, Elahe Minaei et al. · Journal of Medicinal Chemistry · 2018 · 68 citations · Full text

Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer

Daniel Brungs, Elahe Minaei, Ann‐Katrin Piper et al. · Scientific Reports · 2020 · 47 citations · Full text

6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease

Benjamin J. Buckley, Hiwa Majed, Ashraf Aboelela et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 26 citations · Full text

, , +13

Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma

Elahe Minaei, Simon A. Mueller, Bruce Ashford et al. · Frontiers in Oncology · 2022 · 22 citations · Full text

Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer

Daniel Brungs, David T. Lynch, Alison W. S. Luk et al. · World Journal of Gastroenterology · 2018 · 21 citations · Full text

1–5 of 9